These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23908515)

  • 1. Treatment of hyperuricaemia and gout.
    Roddy E; Doherty M
    Clin Med (Lond); 2013 Aug; 13(4):400-3. PubMed ID: 23908515
    [No Abstract]   [Full Text] [Related]  

  • 2. Gout Study Group: update on hyperuricemia and gout.
    Terkeltaub R; Zelman D; Scavulli J; Perez-Ruiz F; Lioté F
    Joint Bone Spine; 2009 Jul; 76(4):444-6. PubMed ID: 19559637
    [No Abstract]   [Full Text] [Related]  

  • 3. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.
    Robinson PC; Horsburgh S
    Maturitas; 2014 Aug; 78(4):245-51. PubMed ID: 24880206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.
    Feher MD; Hepburn AL; Hogarth MB; Ball SG; Kaye SA
    Rheumatology (Oxford); 2003 Feb; 42(2):321-5. PubMed ID: 12595630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic approaches in the treatment of gout.
    Pillinger MH; Mandell BF
    Semin Arthritis Rheum; 2020 Jun; 50(3S):S24-S30. PubMed ID: 32620199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice. Gout.
    Neogi T
    N Engl J Med; 2011 Feb; 364(5):443-52. PubMed ID: 21288096
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperuricaemia and gout.
    Shipley M
    J R Coll Physicians Edinb; 2011 Sep; 41(3):229-33. PubMed ID: 21949921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricaemia and gout: clinical guideline 2003.
    Meyers OL; Cassim B; Mody GM
    S Afr Med J; 2003 Dec; 93(12 Pt 2):961-71. PubMed ID: 14763409
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding treatments for gout.
    Cannella AC; Mikuls TR
    Am J Manag Care; 2005 Nov; 11(15 Suppl):S451-8; quiz S465-8. PubMed ID: 16300459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hyperuricemia and gout based on the guideline for the management of hyperuricemia and gout].
    Taniguchi A
    Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):330-4. PubMed ID: 21139283
    [No Abstract]   [Full Text] [Related]  

  • 13. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.
    Khanna D; Fitzgerald JD; Khanna PP; Bae S; Singh MK; Neogi T; Pillinger MH; Merill J; Lee S; Prakash S; Kaldas M; Gogia M; Perez-Ruiz F; Taylor W; Lioté F; Choi H; Singh JA; Dalbeth N; Kaplan S; Niyyar V; Jones D; Yarows SA; Roessler B; Kerr G; King C; Levy G; Furst DE; Edwards NL; Mandell B; Schumacher HR; Robbins M; Wenger N; Terkeltaub R;
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1431-46. PubMed ID: 23024028
    [No Abstract]   [Full Text] [Related]  

  • 14. Gout and related morbid conditions: pharmacological and SPA therapy.
    Petraccia L; Fraioli A; Liberati G; Lopalco M; Grassi M
    Minerva Med; 2008 Apr; 99(2):203-12. PubMed ID: 18431328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gout].
    Tausche AK
    Z Rheumatol; 2022 Jun; 81(5):400-412. PubMed ID: 35596003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future therapies for gout.
    Pascart T; Richette P
    Expert Opin Pharmacother; 2017 Aug; 18(12):1201-1211. PubMed ID: 28689430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal arthropathies: recognizing and treating "the gouch".
    Quillen DM
    Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
    Stamp LK; Turner R; Khalilova IS; Zhang M; Drake J; Forbes LV; Kettle AJ
    Rheumatology (Oxford); 2014 Nov; 53(11):1958-65. PubMed ID: 24899662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
    Frampton JE
    Drugs; 2015 Mar; 75(4):427-38. PubMed ID: 25724536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gout in 2006: the perfect storm.
    Terkeltaub R
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):82-6. PubMed ID: 17121496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.